Basic Information
AlloVir is a global leader in the development of VST immunotherapies, creating highly innovative allogeneic, off-the-shelf VST therapeutic candidates designed to treat or prevent devastating viral infections and diseases.
Allovir, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2013
info@viracyte.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios